NCT00939692View on ClinicalTrials.gov

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fasted Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

April 30, 2007

Conditions

Healthy

Interventions

DRUG

Topiramate

Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug. IUPAC name 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors

lead

Torrent Pharmaceuticals Limited

INDUSTRY

NCT00939692 - Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fasted Conditions | Biotech Hunter | Biotech Hunter